BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Understanding the differences between value and growth investing is essential. Learn how to choose the right approach for your goals.
24,909 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
A Life360 board director recently sold several thousand shares after exercising options, timing that coincides with a...
Fluor dropped 26% and headlines lit up. But a solid long-term thesis for this EPC powerhouse requires more than a fla...
TJX posted a strong fourth quarter ahead of expectations, yet conservative guidance sparked a pullback in shares as i...
A new move from Google signals a shift in AI compute. This could tilt the balance away from Nvidia in certain cloud a...
NRG Energy surges to the lead in 2025, driven by Larry Coben’s leadership and a strategy to pair robust gas-fired gen...
A seismic shift is brewing in the card world. Capital One's integration with Discover could turn payment processing i...
In 2026, the budget airline reinventing itself is pulling ahead as it monetizes upgrades and smarter distribution, wh...
Natera shows growth through AI-enabled cell-free DNA tests and a widening data moat, positioning it as a leading nate...
A major hedge fund recently boosted its Garrett Motion position, highlighting how hybrid powertrain trends are reshap...
Caesars Entertainment moves to go private in a $17.6 billion deal, and investors are eyeing four lagging U.S. compani...
A clear, investor-friendly look at arcosa (aca) 2025 earnings through the lens of the Q4 2025 earnings call. Learn wh...